Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population.

ABSTRACT:

Background

Although clinical trials involving psychedelic-assisted psychotherapy have not observed short-term increases in the risk of death, limited data exist on mortality associated with hallucinogen use outside of controlled trial settings. We sought to determine whether people with an emergency department visit or hospital admission involving hallucinogen use were at increased risk of all-cause death compared with the general population and with people with acute care presentations involving other substances.

Methods

We conducted a retrospective cohort study using linked health administrative data on all people aged 15 years and older living in Ontario, Canada, from 2006 to 2022. We compared overall and cause-specific mortality between members of the general population

SUBMITTER: Myran DT 

PROVIDER: S-EPMC11879370 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature